| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/28/2002 | WO2001064203A3 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q¿10? |
| 03/28/2002 | WO2001060344A3 Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant staphylococci infections |
| 03/28/2002 | WO2001060342A3 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases |
| 03/28/2002 | WO2001058866A3 Ocular hypotensive lipids |
| 03/28/2002 | WO2001058476A3 Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity |
| 03/28/2002 | WO2001056553A3 Pharmaceutically active aromatic guanylhydrazones |
| 03/28/2002 | WO2001055357A3 Myeloid colony stimulating factor and uses thereof |
| 03/28/2002 | WO2001052825A3 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 03/28/2002 | WO2001051044A3 Substances for use in treating psoriasis |
| 03/28/2002 | WO2001049687A3 Cyclohexene nucleic acids |
| 03/28/2002 | WO2001045686A3 Formulations of adenosine a1 agonists |
| 03/28/2002 | WO2001045484A3 An improved process for preparing simvastatin |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001035936A3 Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides for the treatment of diseases |
| 03/28/2002 | WO2001032885A3 Human lipase |
| 03/28/2002 | WO2001032216A3 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/28/2002 | WO2001023377A9 Polymorphic salt |
| 03/28/2002 | WO2001022955A2 Novel combination of loteprednol and antihistamines |
| 03/28/2002 | WO2001022954A3 Indolyl-3-glyoxylic acid derivatives serving as antitumor agents |
| 03/28/2002 | WO2001019353A3 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/28/2002 | WO2001015677A3 Use of 5-ht1b/1d agonists to treat otic pain |
| 03/28/2002 | WO2001015674A3 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2001007405A3 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 03/28/2002 | WO2000071754A3 Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
| 03/28/2002 | WO2000066102A3 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000056327A9 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 03/28/2002 | WO2000047231A9 Novel antisense inhibition of rad51 |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038038 Methods for treating pathological conditions of abnormal cell proliferation |
| 03/28/2002 | US20020038035 1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 03/28/2002 | US20020038033 Treating tetrahydrofuran derivativ with an oxophilic electrophilic reagent in a manner that is effective to provide the oxazoline compound |
| 03/28/2002 | US20020038032 Orally administrable acid stable antiulcer benzimidazole derivatives |
| 03/28/2002 | US20020038030 For therapy of inflammatory conditions including migraine, rheumatoid arthritis, asthma, and inflammatory bowel disease as well as mediation of the emetic reflex and the modulation of central nervous system (CNS) disorders such as Parkinson's |
| 03/28/2002 | US20020038029 Method for the synthesis of quinoline derivatives |
| 03/28/2002 | US20020038028 For therapy of neurological and psychological disorders are claimed. |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020038017 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 03/28/2002 | US20020038009 Novel human kinase protein and polynucleotides encoding the same |
| 03/28/2002 | US20020037998 For therapy of hepatitis C virus (HCV) infection |
| 03/28/2002 | US20020037933 Sterile pharmaceutical for parenteral administration which comprises the compound 2,6-diisopropylphenol (propofol) with a sterile diluent or carrier; counteracting endotoxin induced deterioration of arterial oxygen tension |
| 03/28/2002 | US20020037931 Treating mood disorders, Parkinson's disease, disorders of the gastrointestinal system, edema formation states and hypertension; for example, 6,7-dihydroxy-8-nitro-3,4-dihydro-2H-naphthalen-1-one |
| 03/28/2002 | US20020037930 Both malignant and benign neoplasms |
| 03/28/2002 | US20020037929 Method of treating angiogenesis-related disorders |
| 03/28/2002 | US20020037928 For treatment of diabetes mellitus; for example sulfonamide derivatives of given formula and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists |
| 03/28/2002 | US20020037927 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/28/2002 | US20020037926 And gabapentin and/or pregabalin or their salts to prevent or ameliorate chronic pain or convulsions; synergistic |
| 03/28/2002 | US20020037925 By administering a drug that increases central nervous system GABA (4-aminobutyric acid) levels; for example gabapentin, valproic acid, progabide, gamma- hydroxybutyric acid, fengabine, cetylGABA, topiramate, tiagabine, or acamprosate |
| 03/28/2002 | US20020037924 Small molecule carbamate or urea hair growth compositions and uses |
| 03/28/2002 | US20020037923 Resorcinolic compounds |
| 03/28/2002 | US20020037921 By adding photoactive dye(s) such as Phloxine B to an aqueous environment containing protozoa such that the resulting concentration of photoactive dye in the aqueous environment is toxic to the protozoa |
| 03/28/2002 | US20020037919 Compositions and methods of paclitaxel for preventing psoriasis |
| 03/28/2002 | US20020037917 Treatment of cancer using lipoic acid in combination with ascorbic acid |
| 03/28/2002 | US20020037915 4-(4-(1- phenyl-5-propylpyrazol4-yl)(1,3-thiazol-2-yl))-5-methylthiothiophene-2 -carboxamidine, for example; complement inhibitors; treating tissue damage, inflammation, or autoimmune diseases |
| 03/28/2002 | US20020037914 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 03/28/2002 | US20020037911 Arylthiazolidinedione derivatives |
| 03/28/2002 | US20020037910 Novel anilide compounds and pharmaceutical compositions comprising them |
| 03/28/2002 | US20020037909 Enamine derivatives |
| 03/28/2002 | US20020037908 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating Alzheimer's disease or Creutzfelds-Jakob disease for example |
| 03/28/2002 | US20020037907 Substituted 2- (S) -hydroxy-3- (piperidin-4-yl-methylamino) -propyl ethers and substituted 2-aryl-2- (R) - hydroxy-1- (piperidin-4-yl-methyl) -ethylamine beta-3 adrenergic receptor agonists |
| 03/28/2002 | US20020037906 Therapeutic agent for intermittent claudication |
| 03/28/2002 | US20020037903 2-(2-pyrimidinyl),4-((hetero)arylalkylsulfonamido), 5-(2-methoxyphenoxy),6-methoxy-pyrimidine derivatives; treating endothelin-mediated disorders such as hypertension, congestive heart failure or chronic renal failure |
| 03/28/2002 | US20020037902 Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy |
| 03/28/2002 | US20020037901 5-((2,4-bis-(4-methylphenylmethoxy)phenyl)methylene)-4-oxo-2-thioxo-3 -thiazolidineacetic acid, for example; treatment and prophylaxis of tumors and tumor metastasis |
| 03/28/2002 | US20020037900 Hydroxamic acid derivatives |
| 03/28/2002 | US20020037899 Compositions containing an inhibitor of dihydrofolate reductase and a folate |
| 03/28/2002 | US20020037898 Nutrient such as vitaminb 6 in the form of an ester, and a co-ester such as butyl benzoate which inhibits esterases; delivery to cells; bioavailability |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037895 Wherein the lactone ring is modified; preventing or treating disorders or diseases mediated by LFA-1 (Leukocyte Function-associated Antigen-1) ICAM-1 (intercellular adhesion molecules) interactions; autoimmune disorders, inflammation |
| 03/28/2002 | US20020037894 5,5-dioxo-2,3,3a,4-tetrahydro-1 H-pyrrolo(2,1-c)(1,2,4)-benzothiadiazin-7-ol, for example; nervous system disorders; alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) modulators |
| 03/28/2002 | US20020037893 Heteroaryl diazabicycloalkanes, their preparation and use |
| 03/28/2002 | US20020037892 Bis-arylsulfones |
| 03/28/2002 | US20020037891 Novel benzo[1,8]naphthyridine derivatives, their preparation and pharmaceutical compositions which comprise them |
| 03/28/2002 | US20020037890 Synergistic; treating grampositive and gramnegative bacterial infections, kits |
| 03/28/2002 | US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth |
| 03/28/2002 | US20020037887 Method for reducing intraocular pressure using indole derivatives |
| 03/28/2002 | US20020037886 Muscarinic agonists |
| 03/28/2002 | US20020037885 Therapeutic compounds |
| 03/28/2002 | US20020037884 Blend containing polyvinyl alcohol |
| 03/28/2002 | US20020037883 Topical mixture |
| 03/28/2002 | US20020037882 Mixture containing glyceride |
| 03/28/2002 | US20020037881 Dry eyes |
| 03/28/2002 | US20020037880 Method of inhibiting hair growth |
| 03/28/2002 | US20020037878 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/28/2002 | US20020037877 Pharmaceutical suspension compositions lacking a polymeric suspending agent |
| 03/28/2002 | US20020037876 Modulator of hepacyte growth factor |
| 03/28/2002 | US20020037875 Antiinflammatory agents; antitumor agent |
| 03/28/2002 | US20020037874 Anticoagulants |
| 03/28/2002 | US20020037873 Biologically active phosphotriester-type compounds |
| 03/28/2002 | US20020037871 Cell proliferation |
| 03/28/2002 | US20020037870 Method of inhibiting cancer cell growth using a vector expressing pRb2/p130 |
| 03/28/2002 | US20020037866 Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 03/28/2002 | US20020037865 Crystal structure |
| 03/28/2002 | US20020037863 Novel anthelmintic combinations |
| 03/28/2002 | US20020037862 Muscle relaxants; sexual disorders |
| 03/28/2002 | US20020037861 Anticonvulsant derivatives useful for preventing the development of Type II diabetes mellitus and Syndrome X |
| 03/28/2002 | US20020037858 Pharmaceutical compositions comprising moexipril magnesium |
| 03/28/2002 | US20020037856 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 03/28/2002 | US20020037855 Stabilized medicament containing cysteinyl derivatives |